Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QUITS: NRT gum in non-daily smokers
NCT02168855Completed
- Start
- Jun 2015
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of nicotine in Tobacco Use Disorder (TUD) (2 arms). Primary endpoint: Smoking Cessation, Continuous 6-month Abstinence at 24 weeks. Started Jun 2015; status: completed.
02
Drugs
nicotine
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02168855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02168855.